載入...

PATH-08. CHALLENGES IN OPTIMIZATION OF MGMT PROMOTER METHYLATION ASSAYS FOR DEVELOPMENT OF COMPANION DIAGNOSIS IN GLIOBLASTOMA

BACKGROUNDS: Despite recent limelight of precision medicine in oncology, effective targeted drugs and diagnostics for molecular markers have not been developed or approved for glioblastoma (GBM) yet. Notably, there remain multiple issues in MGMT testing, including determination of optimal assays and...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Nagane, Motoo, Saito, Kuniaki, Kobayashi, Keiichi, Shimizu, Saki, Sasaki, Nobuyoshi, Yamagishi, Yuki, Shiokawa, Yoshiaki
格式: Artigo
語言:Inglês
出版: Oxford University Press 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847082/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.604
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!